Blood pressure and risk of cancer progression - A possible connection with salt and voltage-gated sodium channel

Medical Hypotheses

Volumn 85, Issue 5, 2015, Pages 591-593

  Djamgoz, Mustafa B A ^a,b  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b CYPRUS INTERNATIONAL UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

POTASSIUM CHANNEL; SODIUM CHLORIDE; VOLTAGE GATED SODIUM CHANNEL; SODIUM CHANNEL; SODIUM INTAKE;

ARTICLE; BLOOD PRESSURE; CANCER CELL; CANCER GROWTH; CANCER RISK; CANCER TISSUE; CLINICAL ASSESSMENT; DISEASE ASSOCIATION; EXTRACELLULAR SPACE; HUMAN; HYPERTENSION; HYPOTHESIS; LIFESTYLE; MALIGNANT NEOPLASTIC DISEASE; METASTASIS POTENTIAL; PROTEIN EXPRESSION; SODIUM BLOOD LEVEL; SODIUM CELL LEVEL; SODIUM TRANSPORT; ADMINISTRATION AND DOSAGE; BLOOD; CHANNEL GATING; DISEASE COURSE; NEOPLASM; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; SODIUM INTAKE;

BLOOD PRESSURE; DISEASE PROGRESSION; HUMANS; ION CHANNEL GATING; NEOPLASMS; SODIUM CHANNELS; SODIUM, DIETARY;

EID: 84946494176     PISSN: 03069877     EISSN: 15322777     Source Type: Journal    
DOI: 10.1016/j.mehy.2015.07.021     Document Type: Article

References (26)

1. Stocks T., Van Hemelrijck M., Manjer J., Bjørge T., Ulmer H., Hallmans G., et al. Blood pressure and risk of cancer incidence and mortality in the Metabolic Syndrome and Cancer Project. Hypertension 2012, 59:802-810.
2. Martin R.M., Vatten L., Gunnell D., Romundstad P. Blood pressure and risk of prostate cancer: Cohort Norway (CONOR). Cancer Causes Control 2010, 21:463-472.
3. Dyer A.R., Stamler J., Berkson D.M., Lindberg H.A., Stevens E. High blood-pressure: a risk factor for cancer mortality?. Lancet 1975, 305:1051-1056.
4. Grossman E., Messerli F.H., Boyko V., Goldbourt U. Is there an association between hypertension and cancer mortality?. Am J Med 2002, 112:479-486.
5. Hamet P. Cancer and hypertension. An unresolved issue. Hypertension 1996, 28:321-324.
6. Fraser S.P., Ozerlat-Gunduz I., Brackenbury W.J., Fitzgerald E.M., Campbell T.M., Coombes R.C., et al. Regulation of voltage-gated sodium channel expression in cancer: hormones, growth factors and auto-regulation. Philos Trans R Soc Lond B Biol Sci 2014, 369(1638):20130105.
7. + channels in human prostate cancer cell lines and their contribution to invasion in vitro. Am J Pathol 1997, 150:1213-1221.
8. Fraser S.P., Diss J.K., Chioni A.M., Mycielska M.E., Pan H., Yamaci R.F., et al. Voltage-gated sodium channel expression and potentiation of human breast cancer metastasis. Clin Cancer Res 2005, 11:5381-5389.
9. + channel SCN5A is a key regulator of a gene transcriptional network that controls colon cancer invasion. Cancer Res 2010, 70:6957-6967.
10. Hernandez-Plata E., Ortiz C.S., Marquina-Castillo B., Medina-Martinez I., Alfaro A., Berumen J., et al. Overexpression of NaV 1.6 channels is associated with the invasion capacity of human cervical cancer. Int J Cancer 2012, 130:2013-2023.
11. Gao R., Shen Y., Cai J., Lei M., Wang Z. Expression of voltage-gated sodium channel alpha subunit in human ovarian cancer. Oncol Rep 2010, 23:1293-1299.
12. +-channel Nav1.7 is necessary for EGF-mediated invasion in human non-small cell lung cancer cells. J Cell Sci 2013, 126:4939-4949.
13. Djamgoz M.B.A., Onkal R. Persistent current blockers of voltage-gated sodium channels: a clinical opportunity for controlling metastatic disease. Recent Pat Anticancer Drug Discov 2013, 8:66-84.
14. Gillet L., Roger S., Besson P., Lecaille F., Gore J., Bougnoux P. Voltage-gated sodium channel activity promotes cysteine cathepsin-dependent invasiveness and colony growth of human cancer cells. J Biol Chem 2009, 284:8680-8691.
15. Ouwerkerk R., Jacobs M.A., Macura K.J., Wolff A.C., Stearns V., Mezban S.D., et al. Elevated tissue sodium concentration in malignant breast lesions detected with non-invasive 23Na MRI. Breast Cancer Res Treat 2007, 106:151-160.
16. Mohan S., Campbell N.R. Salt and high blood pressure. Clin Sci 2009, 117:1-11.
17. Prevarskaya N., Skryma R., Shuba Y. Ion channels and the hallmarks of cancer. Trends Mol Med 2010, 16:107-121.
18. Ross S.B., Fuller C.M., Bubien J.K., Benos D.J. Amiloride-sensitive Na+ channels contribute to regulatory volume increases in human glioma cells. Am J Physiol Cell Physiol 2007, 293:C1181-C1185.
19. Cochet-Bissuel M., Lory P., Monteil A. The sodium leak channel, NALCN, in health and disease. Front Cell Neurosci 2014, 8:132.
20. D'Elia L., Rossi G., Ippolito R., Cappuccio F.P., Strazzullo P. Habitual salt intake and risk of gastric cancer: a meta-analysis of prospective studies. Clin Nutr 2012, 31:489-498.
21. Cole S.W., Sood A.K. Molecular pathways: beta-adrenergic signaling in cancer. Clin Cancer Res 2012, 18:1201-1206.
22. Largent J.A., McEligot A.J., Ziogas A., Reid C., Hess J., Leighton N., et al. Hypertension, diuretics and breast cancer risk. J Hum Hypertens 2006, 20:727-732.
23. Dai Y.N., Wang J.H., Zhu J.Z., Lin J.Q., Yu C.H., Li Y.M. Angiotensin-converting enzyme inhibitors/angiotensin receptor blockers therapy and colorectal cancer: a systematic review and meta-analysis. Cancer Causes Control 2015, [Epub ahead of print].
24. Botteri E., Munzone E., Rotmensz N., Cipolla C., De Giorgi V., Santillo B., et al. Therapeutic effect of β-blockers in triple-negative breast cancer postmenopausal women. Breast Cancer Res Treat 2013, 140:567-575.
25. Li C.I., Daling J.R., Tang M.T., Haugen K.L., Porter P.L., Malone K.E. Use of antihypertensive medications and breast cancer risk among women aged 55 to 74years. JAMA Intern Med 2013, 173:1629-1637.
26. Djamgoz M.B.A. Biophysics of cancer: cellular excitability ("CELEX") hypothesis of metastasis. J Clin Exp Oncol 2014, S1. 10.4172/2324-9110.S1-005.